MARKET

IOBT

IOBT

Io Biotech, Inc.
NASDAQ
0.9450
-0.0051
-0.54%
Closed 18:48 04/29 EDT
OPEN
0.9592
PREV CLOSE
0.9501
HIGH
0.9592
LOW
0.9035
VOLUME
62.52K
TURNOVER
0
52 WEEK HIGH
1.790
52 WEEK LOW
0.6600
MARKET CAP
62.26M
P/E (TTM)
-0.6520
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at IOBT last week (0421-0425)?
Weekly Report · 2d ago
IO Biotech's Co-Founder Mads Hald Andersen Highlights Advances in Cancer Vaccine Research at 2025 AACR Annual Meeting
NASDAQ · 3d ago
IO Biotech Showcases Scientific Leadership Through Cancer Vaccines Educational Session at the American Association for Cancer Research (AACR) Annual Meeting 2025
Barchart · 3d ago
IO Biotech Presents New Data at AACR 2025 Supporting Dual Mechanism and Immune Activation of Cancer Vaccines IO102-IO103 and IO170
Barchart · 4d ago
Weekly Report: what happened at IOBT last week (0414-0418)?
Weekly Report · 04/21 09:07
Weekly Report: what happened at IOBT last week (0407-0411)?
Weekly Report · 04/14 09:06
Weekly Report: what happened at IOBT last week (0331-0404)?
Weekly Report · 04/07 09:06
Can IO Biotech (NASDAQ:IOBT) Afford To Invest In Growth?
Simply Wall St · 04/02 11:23
More
About IOBT
More
IO Biotech Inc is a clinical-stage biopharmaceutical company developing immune-modulating cancer therapies based on T-win technology platform. The Company’s product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression. IO Biotech’s lead product candidate, IO102-IO103, is designed to target the immunosuppressive mechanisms mediated by key immunosuppressive proteins such as IDO and PD-L1. The Company develops a pipeline of product candidates that leverage its T-win technology platform to address targets within the TME. The Company is spin-off of National Cancer for Center Immune Therapy at Herlev University Hospital in Denmark.
Recently
Symbol
Price
%Change

Webull offers IO Biotech Inc stock information, including NASDAQ: IOBT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IOBT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IOBT stock methods without spending real money on the virtual paper trading platform.